COPD: A EUROPEAN PROBLEM WITH EUROPEAN SOLUTIONS

Similar documents
2010 YEAR OF THE LUNG: GOALS AND OBJECTIVES. J. Randall Curtis, MD, MPH Immediate Past President, ATS

9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

American Thoracic Society (ATS) Perspective

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Thursday 29th September 2016

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

RARE DISEASE DAY INFORMATION PACK 28 FEBRUARY 2017 PATIENT INVOLVEMENT: RESEARCH JOIN THE INTERNATIONAL CAMPAIGN TO RAISE AWARENESS FOR RARE DISEASES

U.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate

Almost 1 in 10 adults have been diagnosed with diabetes. Alabama is ranked fifth in prevalence of diabetes in the United States and its territories.

PROactive. Physical Activity as a Crucial Patient Reported Outcome in COPD. Thierry.troosters [AT] med.kuleuven.be Info [AT] proactivecopd.

How Can We Protect Scotland s Most Vulnerable Lungs from Air Pollution? British Lung Foundation 2017 blf.org.uk/scotland

Bronchiectasis. What is bronchiectasis? What causes bronchiectasis?

An Overview of Asthma - Diagnosis and Treatment

The SEMPAC Center is funded by the National Cancer Institute U54 CA

activism Animal Ethics in 2017 A year in retrospect:

FACT SHEET % 15.0% Percent 10.0%

European Patients Academy on Therapeutic Innovation

Epidemiology of COPD Prof. David M. Mannino, M.D.

About BNM.

ERS School and postgraduate education

Respiratory diseases in Ostrołęka County

Great American Smokeout November 15, 2018 Communications Toolkit

COPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum

Respiratory diseases in the world. Realities of today opportunities for tomorrow

Prof. Tezer Kutluk, MD PhD, FAAP President Prevention Strategies in Cancer Union for International Cancer Control (UICC) 08 September 2016

Trends in Pneumonia and Influenza Morbidity and Mortality

Commissioning for Better Outcomes in COPD

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)

Overview. DEAR Advocate,

Tobacco control and the FCTC: Is the EU important at national level and in Sweden?

Join Us in the Fight for Air 1. Join us in the fight for air.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Innovative Approaches and Proven Strategies for Maximizing Reach: Case Studies to Highlight Promising and Best Practices

New Mexico Tobacco Cessation Services and Resources

Respiratory Therapists as COPD Educators

American Cancer Society

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

MALAYSIAN THORACIC SOCIETY LUNG FUNCTION TESTS EDUCATION PROGRAMME

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014

Chronic Obstructive Pulmonary Disease (COPD).

World Hepatitis Alliance Strategic Plan 2015

Comments to the U.S. Food and Drug Administration Regarding the Patient-Focused Drug Development Re: Docket No. FDA-2012-N-0967

WHO Framework Convention on Tobacco Control. Submission from the National Heart Forum (UK)

Guideline scope Smoking cessation interventions and services

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Presenter Dr. Masoud Mohammadnezhad Associate Professor, Health Promotion Department of Public Health & Primary Health Care Fiji National University

Smoking vs Smokeless. Tobacco is a plant that contains nicotine. Cigars and pipes contain more tar and other chemicals.

National COPD Audit Programme

PDF HEART DISEASE STATISTICS 2017 DOWNLOAD

CAMPAIGNING FOR QUITS The QUIT Campaign

New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

First European Parliament Conference on Complementary and Alternative Medicine, CAM.

Tobacco and Poverty: a Vicious Circle. Activities celebrated around the world. Follow-up actions and objectives

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

WHO Public Hearings on the Framework Convention on Tobacco Control October 2000 Geneva, Switzerland Written Testimony

Chronic Obstructive Pulmonary Disease (COPD)

Optimal Asthma Control Data Specifications

Where do we go from here?

Executive Summary. Your life, your responsibility. 2nd Colorectal Cancer Patient Conference 5th & 6th July 2013 Barcelona Spain

The Life Course Immunisation Initiative

REDUCING THE IMPACT OF DIABETES ON THE

Dr Gro Brundtland, Director General, WHO, on November 14, 1996, commenting on WHO s Tobacco Free Initiative.

The State of Asthma in Arkansas

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning

Viral hepatitis - The patients impact in Bulgaria

Bridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide

1. Global Fund on HIV/AIDS, Tuberculosis and Malaria

AIDS: Impact On Public Policy: An International Forum: Policy, Politics, And AIDS

WHO Secretariat Dr Timothy Armstrong Coordinator, Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion

Fighting for Air, In Emphysema

Achieving Quality and Value in Chronic Care Management

National COPD Audit Programme

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

Chronic Obstructive Pulmonary Disease (COPD) Measures Document

ACTIONS AGAINST CHRONIC RESPIRATORY DISEASES (CRDs( ITALY

Global Strategies to Improve Cancer Care and Control

Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474

DEAR Advocate, Project prevent youth coalition presents

Report on the Results of the Year of the Dolphin 2007/2008

OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures

Healthy Workplaces for All Ages Promoting a sustainable working life

World Occupational Therapy Day 2013

I AM A CITIES AND GOVERNMENT TOOLKIT AND I WILL INSPIRE POLICY MAKERS AND CITIES TO MAKE A DIFFERENCE

Pathology of Asthma Epidemiology

Strategy for the prevention and control of Non Communicable. Diseases in the Democratic People s Republic of Korea 2014-

People with asthma who smoke. The combination of asthma, a chronic airway disease, and smoking increases the risk of COPD even more.

The County of Santa Clara

Chronic Obstructive Pulmonary Disease Guidelines and updates

Collaborative Project of the 7th Framework Programme. WP6: Tools for bio-researchers and clinicians

JUNE 2011 CHAMPIONS REPORT

Asthma and Chronic Obstructive Pulmonary Disease

[IRELAND 2040 TOBACCO FREE IRELAND (HSE) FEEDBACK] March 16, 2017

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Almirall grants Invida commercial rights for Aclidinium in Australia and New ZealandAlmirall????? (Invida)??????????? Aclidinium?????

Chronic respiratory disease: towards better treatments

FACT SHEET: Federal Parity Task Force Takes Steps to Strengthen Insurance Coverage for Mental Health and Substance Use Disorders

New Mexico Department of Health Tobacco Use Prevention and Control

Transcription:

COPD: A EUROPEAN PROBLEM WITH EUROPEAN SOLUTIONS THE ERS actions to fight COPD Professor Nikos M. Siafakas MD, PhD Medical School, University of Crete President of the European Respiratory Society

Dedicated to: Sharing scientific knowledge Fighting lung diseases Promoting lung health 10000 members- over 100 countries Annual Congress >20000 participants

2010: The Year of the Lung Declaration 6 December 2009, Cancun, Mexico Hundreds of millions of people struggle each year for life and breath due to lung diseases, including tuberculosis, asthma, pneumonia, influenza, lung cancer and chronic obstructive pulmonary disorder, and more than 10 million die. Lung diseases afflict people in every country and every socioeconomic group, but take the heaviest toll on the poor, the old, the young and the weak;

WE RECOGNIZE THAT: Tobacco use remains legal, although it kills more than 5 million people each year, including 3.5 million who die of COPD, and dit affects the health of hundreds d of thousands of others who are exposed to its effects secondhand;

2010 The Year of the Lung The 2010 Year of the Lung is being organised by the Forum of International Respiratory Societies (FIRS). FIRS includes the European Respiratory Society (ERS), the Asociacion Latinoamericana del Thorax (ALAT), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), the Asia Pacific Society of Respirology (APSR), the International Union Against Tuberculosis and Lung Disease (The Union), and the Pan African Thoracic Society (PATS). Together with close to 200 official partners and supporters from all over the world www.2010yearofthelung.org

Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases.

Percent Change in Age-Adjusted Death Rates, U.S., 1965-1998 1998 Proportion of 1965 Rate 3.0 Coronary 25 2.5 Heart Disease Stroke Other CVD COPD All Other Causes 2.0 1.5 10 1.0 0.5 0 59% 64% 35% +163% 7% 1965-1998 1965-1998 1965-1998 1965-1998 1965-1998 Source: NHLBI/NIH/DHHS

ERS against Tobacco ERS-Tobacco Control Committee ELF- information to the public Smoke Free Partnership

31 st May 2010 WNTD 1 2 3 4 5 6

31 st May 2010 WNTD 1 2 3 4 5 6

31 st May 2010 WNTD 1 2 3 4 5 6

ELF- AWARD 2010 35 MEMBERS OF EUROPEAN PARLIAMENT HOW HAVE SIGN THE PLEDGE IN SUPPORT OF TOBACCO CONTROL IN EUROPE

March 10 th - ERS led Year of the Lung event at Fifth WHO Ministerial i i on Health and Environment This successful YOL side event was well attended by WHO policy makers

Promoting Clean Air in Europe ERS had several meetings with governments and MEPs to advocate for a strong Air Quality Directive in Europe. ERS also lobbied on the proposal for a White paper on Climate change and two ERS amendments have been accepted to the draft report.

Brainstorming on Research Gap 1. Main Challenges identified d Lifestyle and lung health Early origins of adult lung diseases Lungs and the environment Lung infection and defenses Lung diseases in an ageing population 2. Research Gaps identified New investigation Technologies/Imaging New diagnostic tools/biomarkers New treatments/medication

April 13 th High level YOL Event Emphasis on research priorities iti for lung diseases in the European Union. National Societies and partners of the Year of the Lung came from all around Europe.

April 13 th Event

In-Kind Contribution A non-monetary contribution to the consortium eg personnel, equipment, consumables etc 2 Billion EURO In kind + Cash 1Billion Euro 1Billion Euro In kind

COPD PROActive To develop Patient Reported Outcomes that t capture relevant dimensions of physical activity (PA) and are sensitive to change with interventions including pharmacotherapy py 20

The PROActive consortium EFPIA members Patient / Scientific organizations oga ato Academic partners SME

SURVEILLANCE and MANAGEMENT

EARLY DIAGNOSIS PROMOT Spirometry and quesionaires GLOBAL PROJECT = World Spirometry Day

World Spirometry Day, October 14

Raising awareness Contact your local radio, newspaper and TV for coverage. If you are paying a local PR agency, you may decide to create press releases. Circulate posters and flyers at local pharmacies and surgeries. Advertise in local free newspapers. Larger events: organise small press conference/opening ceremony for journalists. Supply patient t information in waiting areas to educate people queuing. Please download the WSD kit for examples that can be edited www.yearofthelung.org/1633-world-spirometry-day-kit.htm ld t d ht

ERS/ELF White Book 1

WHITE BOOK II is in preparation and is going to be presented in Barcelona in the ERS congress

COPD AUDIT

EUROPEAN STANDARD OF CARE FOR EXACERBATION OF COPD COMPARISON OF TREATMENT PRACTICE OF HOSPITAL ADMITTED EXACERBATIONS IN COPD PATIENTS BY AN WEB-BASED BASED AUDIT

European Lung Foundation Public voice of the European Respiratory Society Website about lung health and disease for public Viewed by at least 1,500 unique visitors per day). ERS and ELF Coordinators of World Spirometry Day, the first p y y, ever global lung function testing event (October 14, 2010).

Informing about COPD ELF website: www.european-lung-foundation.org English, French, German, Italian, Spanish, Polish, Russian, Greek Developed from ERS resources or by ERS member COPD resources COPD section; visited 36,184 times in last 10 months Factsheets Living well with COPD ; downloaded >1,000 ERS patient guidelines

CONCLUSIONS I COPD is a very common but deadly disease All Health Organizations that care about patients with COPD must join forces to fight the disease and convince the decision Makers :

CONCLUSION II To support: Stronger laws against tobacco Efforts for early diagnosis of COPD Research on the pathophysiology of COPD Research for new treatment and better management Surveillance projects

WE LOOK FORWARD TO WELCOMING YOU IN BARCELONA!